Balogun O, Nejak-Bowen K
Semin Liver Dis. 2024; 44(2):209-225.
PMID: 38772406
PMC: 11268267.
DOI: 10.1055/s-0044-1787076.
Balogun O, Nejak-Bowen K
Semin Liver Dis. 2023; 43(4):446-459.
PMID: 37973028
PMC: 11256094.
DOI: 10.1055/s-0043-1776760.
Jerico D, Cordoba K, Sampedro A, Jiang L, Joucla G, Cabanne C
Life (Basel). 2022; 12(11).
PMID: 36430993
PMC: 9694773.
DOI: 10.3390/life12111858.
Ricci A, Pierro E, Marcacci M, Ventura P
Diagnostics (Basel). 2021; 11(12).
PMID: 34943446
PMC: 8700611.
DOI: 10.3390/diagnostics11122205.
Wang B
Transl Gastroenterol Hepatol. 2021; 6:24.
PMID: 33824928
PMC: 7838531.
DOI: 10.21037/tgh-2020-01.
Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators.
Bustad H, Kallio J, Vorland M, Fiorentino V, Sandberg S, Schmitt C
Int J Mol Sci. 2021; 22(2).
PMID: 33445488
PMC: 7827610.
DOI: 10.3390/ijms22020675.
Therapeutic strategies for acute intermittent porphyria.
Zhao L, Wang X, Zhang X, Liu X, Ma N, Zhang Y
Intractable Rare Dis Res. 2020; 9(4):205-216.
PMID: 33139979
PMC: 7586882.
DOI: 10.5582/irdr.2020.03089.
Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria.
Fu Y, Jia J, Yue L, Yang R, Guo Y, Ni X
Front Pharmacol. 2019; 10:1018.
PMID: 31572191
PMC: 6753391.
DOI: 10.3389/fphar.2019.01018.
Heme biosynthesis and the porphyrias.
Phillips J
Mol Genet Metab. 2019; 128(3):164-177.
PMID: 31326287
PMC: 7252266.
DOI: 10.1016/j.ymgme.2019.04.008.
Effects of -aminolevulinic acid dehydratase silencing on the primary and secondary metabolisms of citrus.
Killiny N, Hijaz F, Nehela Y, Hajeri S, Gowda S
Plant Direct. 2019; 2(7):e00072.
PMID: 31245736
PMC: 6508816.
DOI: 10.1002/pld3.72.
Porphyria: What Is It and Who Should Be Evaluated?.
Edel Y, Mamet R
Rambam Maimonides Med J. 2018; 9(2).
PMID: 29553924
PMC: 5916231.
DOI: 10.5041/RMMJ.10333.
Psychiatric Aspects of Acute Porphyria: a Comprehensive Review.
Duque-Serrano L, Patarroyo-Rodriguez L, Gotlib D, Molano-Eslava J
Curr Psychiatry Rep. 2018; 20(1):5.
PMID: 29392446
DOI: 10.1007/s11920-018-0867-1.
Tyrosinemia type I and not treatment with NTBC causes slower learning and altered behavior in mice.
Hillgartner M, Coker S, Koenig A, Moore M, Barnby E, MacGregor G
J Inherit Metab Dis. 2016; 39(5):673-682.
PMID: 27271696
DOI: 10.1007/s10545-016-9949-6.
δ-Aminolevulinic acid dehydratase single nucleotide polymorphism 2 (ALAD2) and peptide transporter 2*2 haplotype (hPEPT2*2) differently influence neurobehavior in low-level lead exposed children.
Sobin C, Flores-Montoya M, Gutierrez M, Parisi N, Schaub T
Neurotoxicol Teratol. 2014; 47:137-45.
PMID: 25514583
PMC: 4291309.
DOI: 10.1016/j.ntt.2014.12.001.
δ-Aminolevulinic acid dehydratase single nucleotide polymorphism 2 and peptide transporter 2*2 haplotype may differentially mediate lead exposure in male children.
Sobin C, Parisi N, Schaub T, Gutierrez M, Ortega A
Arch Environ Contam Toxicol. 2011; 61(3):521-9.
PMID: 21327641
PMC: 3188358.
DOI: 10.1007/s00244-011-9645-3.
Blood lead levels and δ-ALAD inhibition in nestlings of Eurasian Eagle Owl (Bubo bubo) to assess lead exposure associated to an abandoned mining area.
Gomez-Ramirez P, Martinez-Lopez E, Maria-Mojica P, Leon-Ortega M, Garcia-Fernandez A
Ecotoxicology. 2010; 20(1):131-8.
PMID: 21076940
DOI: 10.1007/s10646-010-0563-3.
Polymorphisms of delta-aminolevulinic acid dehydratase (ALAD) and peptide transporter 2 (PEPT2) genes in children with low-level lead exposure.
Sobin C, Gutierrez M, Alterio H
Neurotoxicology. 2009; 30(6):881-7.
PMID: 19723536
PMC: 2789866.
DOI: 10.1016/j.neuro.2009.08.006.
Diphenyl diselenide-induced seizures in rat pups: possible interaction with glutamatergic system.
Prigol M, Wilhelm E, Stangherlin E, Barancelli D, Nogueira C, Zeni G
Neurochem Res. 2007; 33(6):996-1004.
PMID: 18080189
DOI: 10.1007/s11064-007-9538-z.
Lead and delta-aminolevulinic acid dehydratase polymorphism: where does it lead? A meta-analysis.
Scinicariello F, Murray H, Moffett D, Abadin H, Sexton M, Fowler B
Environ Health Perspect. 2007; 115(1):35-41.
PMID: 17366816
PMC: 1797830.
DOI: 10.1289/ehp.9448.
Neuropsychiatric porphyria in patients with refractory epilepsy: report of three cases.
Winkler A, Peters T, Elwes R
J Neurol Neurosurg Psychiatry. 2005; 76(3):380-3.
PMID: 15716531
PMC: 1739528.
DOI: 10.1136/jnnp.2003.033951.
